Maysa Al-Hussaini

Acting Chairperson, Department of Cell Therapy and Applied Genomics (CTAG)

Education and Training

M.B./B.S. University of Jordan, School of Medicine, Jordan
Higher Specialization Degree in Pathology, University of Jordan
Pathology Resident, Jordan University Hospital, Jordan
Specialist Registrar in Histopathology/ Cytopathology, Royal Victoria Hospital, U.K
Honorary SHO in Dermatopathology and Neuropathology, Royal Victoria Hospital, U.K

Board Certifications

Membership of the Royal College of Pathologists, U.K
Jordanian Board of Pathology, Jordan Medical Council

Experience

2006 Present Consultant Histopathologist/Cytopathologist and Neuropathologist, Department of Pathology and Laboratory Medicine,King Hussein Cancer Center (KHCC), Jordan
2012 Locum at Neuropathology, Institute of Pathology, Royal Victoria Hospital, U.K.
2003-2006 Consultant Histopathologist /Cytopathologist, Department of Pathology, Jordan University Hospital, University of Jordan, Jordan
2006 Locum in Histopathology, Department of Pathology, Royal Manchester Children’s Hospital Trust, U.K.
2004 Locum in Histopathology/Cytopathology andDermatopathology, Department of Pathology, Royal Victoria Hospital, U.K.
2001-2003 SpR in Histopathology /Cytopathology, Department of Pathology, Royal Victoria Hospital, U.K.
2000-2001 Honorary SHO in Dermatopathology and Neuro-Pathology, Department of Pathology, Royal Victoria Hospital, U.K.
1999 Teaching Assistant, Department of Pathology, University of Jordan, Jordan
1998-1999 Consultant Histopathologist/Cytopathologist, Ministry of Health Hospital, Jordan
Achievements:
Former President, Arab Division of the International Academy of Pathology
Examiner, the Royal College of Pathologists
Inspector and Team Leader, the College of American Pathologists
Chair, Institutional Review Board, KHCC

Professional Memberships

2005 Member of the British Division of the International Academy of Pathology (BDIAP)
2003 Member of the Arab Division of the International Academy of Pathology (ADIAP)
2003 Member of the Jordanian Society of Pathology
2003 Participant of the Continuous Professional Development Scheme (CPD)/UK
2003 Member of the General Medical Council, UK
2002 Member of Royal College of Pathologists, London, UK
1994 Member of Jordan Medical Association

Awards And Honors

Aug July 2002 Competitive scholarship for postgraduate training in Dermatopathology/Neuropathology, Belfast, UK, from the University of Jordan
June 1998 Graduated with 3.68 out of 4.0 (with Merits), in the Higher Specialization Degree in Pathology, University of Jordan
June 1993 Graduated with Merits from Medical School
June 1987 Awarded one out of ten competitive scholarships by theMinistry of Higher Education, Jordan to study Medicine at theUniversity of Jordan
June 1987 Graduation with Distinction; General Secondary Education Certificate/Jordan

Publications

Al-Hussaini MA, Stockman A, Foster HE, McCluggage WG. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma. Histo. 2004; 44(2) :109-115.
Sumathi VP, Al-Hussaini M, Connolly LE et al. Endometrial stromal neoplasms are immunoreactive with WT-1 antibody. Int J Gynecol Pathol. 2004; 23(3):241-7.
Enam A. Khalil, Fatma U.Afifi, Maysa Al-Hussaini. Morphological and Histological Evaluation of the Wound Healing Effect of Some Medicinal Plants Used Traditionally in Jordan in Mice (Mus musculus). J. Ethnopharmacology. 2007 Jan 3; 109:104-12.
Ibrahim Qaddoumi, Awni Musharbash, Maher Elayyan, Asem Mansour, Maysa Al-Hussaini, James Drake, Maisa Swaidan, Ute Bartels , Eric Bouffet. Closing the survival gap: Implementation of medulloblastoma protocolsin a low-income country through a twinning program. Int. J Cancer. 2008;122:1203-1206.
M. Al-Hussaini, L Hirschowitz, W G McCluggage. Uterine neoplasms composed of rhabdoid cells do not exhibit loss of INI1 immunoreactivity and are not related to childhood malignant rhabdoid tumour.Int J Gynecol Pathol. 2008 Apr;27(2):236-42.
Abuznaid M, Sallam AS, Hamdan I, Al-Hussaini M, Bani-Jaber A. Diclofenac-bismuth complex: synthesis, physiochemical and biological evaluation. Drug Dev Ind Pharm. 2008 Apr: 34(4):434-44.
Qaddoumi I, Ezam N, Swaidan M, Jaradat I, Mansour A, Abuirmeileh N, Bouffet E, Al-Hussaini M.Diffusebrain stem glioma and impact of upfront disclosure of prognosis with parents and families. J Child Neurol. 2009 Apr; 24(4):460-5.
Al-Hussaini M, Sultan I, Abuirmileh N, Jaradat I, Qaddoumi I. Pineal Gland Tumors; experience from the SEER database. J Neurooncol. 2009 Sep; 94(3):351-8.
Sultan I, Masarweh M, Ismael T, Al-Hussaini M, Almousa A, Ali HM, Rodriguez-Galindo C, Ghandour K.From upfront nephrectomy to preoperative chemotherapy and back: a single institution experience in the treatment of Wilms tumor. J Pediatr Hematol Oncol. 2009 May; 31(5):333-8.
Sultan I, Qaddoumi I, Rodriguez-Galindo C, Al Nassan A, Ghandour K, Al-Hussaini M. Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors. Pediatr Blood Cancer. 2010 Jan; 54(1):35-40.
Hadidy AM, Nadi MM, Ahmad TM, Al-Hussaini MA, Al-Abaddi AA, Musharbash AF, Maani WS. Descriptive epidemiological analysis, MRI signals intensity and histopathological correlations of meningiomas. Neurosciences (Riyadh). 2010 Jan;15(1):11-4.
Sultan I, Wilson MW, Nawaiseh I, Mehyar M, Kharma S, Al-Qudimat M, Hazin R, Alalami A, Jaradat I, Al-Husseini M, Abdeen G, Rodriguez-Galindo C, Qaddoumi I. Enucleation for retinoblastoma: the experience of a single center in Jordan. Int. Ophthalmol. 2010 Aug; 30(4):407-14.
Matalka I, Al Hamad M, Al-Hussaini M, Alzoubi FQ. The incidence of Epstein-Barr virus in nasopharyngeal carcinoma of Jordanian patients. Eur Arch Otorhinolaryngol. 2012 Jan;269(1):229-34
Salem A, Hashem SA, Al-Rashdan A, Ezam N, Nour A, Alsharbaji A, Sughayer M, Mohamad I, Elyan M, Addas A, Al-Hussaini M, Almousa A. The challenges of managing glioblastoma multiforme in developing countries: a trade-off between cost and quality of care. Hematol Oncol Stem Cell Ther. 2011;4(3):116-20.
Tihan T, Ersen A, Qaddoumi I, Sughayer MA, Tolunay S, Al-Hussaini M, Phillips J, Gupta N, Goldhoff P, Baneerjee A. Pathologic Characteristics of Pediatric Intracranial Pilocytic Astrocytomas and Their Impact on Outcome in 3 Countries: A Multi-institutional Study. Am J Surg Pathol. 2012 Jan;36(1):43-55.
Hashem SA, Salem A, Al-Rashdan A, Ezam N, Nour A, Alsharbaji A, Rejeeth C, Mohamad I, Sughayer M, Elyan M, Al-Hussaini M, Addasi A, Almousa A. Radiotherapy with concurrent or sequential temozolomide in elderly patients with glioblastoma multiforme. J Med Imaging Radiat Oncol. 2012 Apr;56(2):204-10.
Swaidan M, Al-Hussaini M, Sultan I, Mansour A. Radiological findings in gliosarcoma. A single Institution Experience. The Neuroradiology Journal Digital. 2012; 2: 173-180.
Al-Jumaily U, Ayyad O, Masarweh M, Ghandour K, Almousa A, Al-Hussaini M, Ferrari A, Sultan I. Improved care of rhabdomyosarcoma in Jordan using less intensive therapy. Pediatr Blood Cancer. 2013 Jan;60(1):53-8.. doi: 10.1002/pbc.24241. [Epub ahead of print]. 2012 Jun 28.
Al-Hussaini M, Usama Al-Jumaily, Maisa Swaidan, Awni Musharbash, Sameh Hashem. Brain Stem Glioma, a clinicopathological study from a single cancer center. Brain Tumor Pathol. 2013 Apr;30(2):84-92. DOI 10.1007/s10014-012-0110-4. 2012 Jul 4.
Al-Loh S, Al-Hussaini M. Undifferentiated endometrial carcinoma, a diagnosis frequently overlooked. Arch Pathol Lab Med. 2013 Mar;137(3):438-42. doi: 10.5858/arpa.2011-0461-RS.
Al-Hussaini M, Swaidan M, Al-Jumaily U, Musharbash A. Central nervous system tumors in the first year of life, a clinical and pathologic experience from a single cancer center. Childs Nerv Syst. 2013 Mar 24; 29 (10): 1883-1891.
Lataifeh IM, Al-Hussaini M, Uzan C, Jaradat I, Duvillard P, Morice P. Villoglandular papillary adenocarcinoma of the cervix: a series of 28 cases including two with lymph node metastasis. Int J Gynecolo Cancer. 2013 April 1. [Epub ahead of print].
Al-Hussaini M, Iyad Sultan. A Population-based Study on Pediatric Spinal Cord Tumors, with Emphasis on Intramedullary Ones. J Spine. 2013 June, 2 (4); 137. doi:10.4172/2165-7939.1000137
Al-Hussaini M, Dissi N, Al-Jumaily U, Swaidan M. Atypical Teratoid Rhabdoid Tumor in Childhood, 15 Cases of a Single Institute Experience. Turk Patoloji Derg. 2014; 30(1). doi: 10.5146/tjpath.2013.01213.
Yousef YA, Hajja Y, Nawaiseh I, Mehyar M, Sultan I, Deebajah R, Rawashdeh K, Khurma S, Jaradat I, Al-Hussaini M. A Histopathologic Analysis of 50 Eyes Primarily Enucleated for Retinoblastoma in a Tertiary Cancer Center in Jordan.Turk Patoloji Derg. 2014; 30(3): 171-177. doi: 10.5146/tjpath.2014.01260.
Al-Hussaini M, Abu-Hmaidan A. Use of human surplus biospecimens in research: a survey from a cancer center. East Mediterr Health J. 2014 Jun 18; 20(6):378-84.
Nawaiseh I, Al-Hussaini M, Alhamwi A, Meyar M, Sultan I, Alrawashdeh K, Jaradat I, Yousef YA. The Impact of Growth Patterns of Retinoblastoma (Endophytic, Exophytic, and Mixed Patterns). Turk Patoloji Derg. 2014 Oct 10. doi: 10.5146/tjpath.2014.01278. [Epub ahead of print].
Yousef YA, Al-Hussaini M, Mehyar M, Sultan I, Jaradat I, Al Rawashdeh K, Khurma S, Deebajah R, Nawaiseh I. Predictive value of TNM classification, international classification and Reese-Ellworth staging of retinoblastoma for the likelihood of high-risk pathologic features. Retina. 2015 Sep; 35(9):1883-9. doi: 10.1097/ IAE.0000000000000547.
Amayiri N, Tabori U, Campbell B, Bakry D, Aronson M, Durno C, Rakopoulos P, Malkin D, Qaddoumi I, Musharbash A, Swaidan M, Bouffet E, Hawkins C, Al-Hussaini Mand On behalf of BMMRD consortium. High frequency of Mismatch Repair Deficiency among Pediatric High Grade Gliomas in Jordan. Int. J. Cancer 2015 Aug 8. DOI: 10.1002/ijc.29724
Tamimi AF, Tamimi I, Abdelaziz M, Saleh Q, Obeidat F, Al-Husseini M, Haddadin W, Tamimi F. Epidemiology of Malignant and Non-Malignant Primary Brain Tumors in Jordan. Neuroepidemiology. 2015;45(2):100-8. doi: 10.1159/000438926. Epub 2015 Aug
Al-Hussaini M, Dissi N, Souki C, Amayiri N. Atypical teratoid/ rhabdoid tumor, an immunohistochemical study of potential diagnostic and prognostic markers. Neuropathology. 2016 Feb;36(1):17-26. doi: 10.1111/neup.12231. Epub 2015 Jul 24.
Amayiri N, Swaidan M, Yousef Y, Halalsheh H, Abu-Hijlih R, Kalaldeh S, Barbar M, Elayyan M, Faqih N, Al-Hussaini M, Mehyar M, Bartels U, Drake J, Musharbash A, Bouffet E. Review of management and morbidity of pediatric craniopharyngioma patients in a low-middle-income country: a 12-year experience.Childs Nerv Syst. 2017 Apr 28. doi: 10.1007/s00381-017-3411-4.
Nisreen Amayiri , Maisa Swaidan, Najyah Abu-Rumieleh, Al-Husseini M, Tariq Tihan, James Drake, Awni Musharbash, Ibrahim Qaddoumi, Uri Tabori, Hadeel Halalsheh, Ute Bartels, Eric Bouffet. Video-teleconferencing in Pediatric Neuro-oncology; Ten Years of Experience. Journal of Global Oncology (JGO). 2017 May. DOI:10.1200/JGO.2016.008276
Al-Hussaini M, Al-Othman Y, Hijazi E, McCluggage WG. A Report of Ovarian Sertoli-Leydig Cell Tumors with Heterologous Intestinal-type Glands and Alpha Fetoprotein Elevation and Review of the Literature. Int J Gynecol Pathol. 2017 Jun 2. doi: 10.1097/PGP.0000000000000408. [Epub ahead of print]. PMID: 28582340.
Yacoub A. Yousef, Abdelghani Tbakhi, Al-Hussaini M, Ibrahim AlNawaiseh, Ala Saab, Amal Afifi, Maysa Naji , Mona Mohammad, Rasha Deebajah, Imad Jaradat, Iyad Sultan, Mustafa Mehyar. Mutational Analysis of the RB1 Gene and the Inheritance Patterns of Retinoblastoma in Jordanian Patients. Familial Cancer. 2017 Aug 12. doi: 10.1007/s10689-017-0027-5
Bayan Maraqa, Isam Lataifeh, Lian Ottai, Osama Badran, Yasar Qutaiba Nouri, Ibtihal Isam, Al-Hussaini M.Prevalence of Abnormal Pap Smear; a Descriptive Study from a Cancer Center in a Low-Prevalence Community. Asia Pacific Journal of Cancer Prevention (APJCP), 2017 November; 18:3117-3121.
Abu Shawar M, Abu Shawer O, Souleiman M, Akkawi M, Alshakhatreh O, Altamimi T, Al-Omari A, Al-Hussaini M.Hematological Markers of Lung Metastasis in Stage IV Colorectal Carcinoma. J Gastrointest Cancer. 2018 March. DOI: 10.1007/s12029-018-0089-0.
Jamila G. Hiasat, Alaa Saleh, Maysa Al-Hussaini, Ibrahim Al Nawaiseh, Mustafa Mehyar, Monther Qandeel, Mona Mohammad, Rasha Deebajah, Iyad Sultan, Imad Jaradat, Asem Mansour, Yacoub A. Yousef. The Predictive Value of Magnetic Resonance Imaging of Retinoblastoma for the likelihood of High Risk Pathologic Features. Eur J Ophthalmol. 2018 Jun 1:1120672118781200. doi: 10.1177/1120672118781200.
Mahmoud Alawi, Mohanad Masaad, Maysa Al-HussainiComparative study of persistent organic pollutant (POP) (chlorinated pesticides, PCBs, and dioxins/furans) concentrations in cancer-affected human organs with those of healthy organs. J. Environmental Monitoring and Assessment. August 2018, 190:470.
Al-Hussaini M, Isam Lataifeh , Imad Jaradat , Ghadeer Abdeen, Lian Ottai, Osama Badran , Areej Abu Sheikha , Abdulmajeed Dayyat, Mousa El Khaldi , Shaymaa Ashi Al-Loh, Undifferentiated Endometrial Carcinoma, an Immunohistochemical Study Including PD-L1 testing of a Series of Cases from a Single Cancer Center. Int J Gynecol Pathol. 2018 Jul 27. doi: 10.1097/PGP.0000000000000449
Amal Al Omari, Hadeel Abdelkhaleq, Maysa Al-Hussaini, Rim Turfa, Nour Awad, Manal M. Hassan, Mahmoud A. Alfaqih, and Christopher R. Garrett. Validation of the survival benefits of metformin in Middle Eastern patients with type II diabetes mellitus and colorectal cancer. J Glob Oncol. 2018 Jul;(4):1-10. doi: 10.1200/JGO.18.00018.
Mamoun Ahram, Justin Ammarin, Haya Souradi, Maysa Al-Hussaini. Association of MicroRNAs with the Clinicopathologic Characteristics of Ependymoma. Journal of Molecular Neuroscience. 2018.
Amal Al-Tabba, Amal Al-Omari, Maysa Al-Hussaini. Appraisal of the Jordanian Law for Data Sharing in Stem Cell Research: in the Light of the “GA4GH Framework” for Innovative Cancer Care.Accepted at IEEE Xplore, January 2019. DOI:10.1109/CANCERCARE.2018.8618158
Amal Al-Tabba, Maysa Al-Hussaini, Amal Al-Omari. Functional and Non-Functional Requirements for Susceptibility Genetic Testing in Cancer Care: The Case of BRCA1/2 Testing in Jordan. Accepted at IEEE Xplore, January 2019. DOI: 10.1109/CANCERCARE.2018.8618154
Abu-Shawer O, Abu-Shawer M, Nader Hirmas, Alhouri A, Massad A, Alsibai B, Sultan H, Hammo H, Souleiman M , Shebli Y , Al-Hussaini M. Hematologic Markers of Distant Metastases and Poor Prognosis in Gynecological Cancers. BMC Cancer. 2019 Feb 12;19(1):141. doi: 10.1186/s12885-019-5326-9.
Abu-Shawer O, Abu-Shawer M, Haimour A, Alhouri A, Alkhatib A, Abki M, Alqaisi O, Hamdan O, Alsaqri R, Ismail S, Altamimi T, Al-Hussaini M. Hematologic Markers of Distant Metastases in Gastric Cancer. J Gastrointest Oncol. Vol 10, No 3 (June 2019). 529-536.
Yanal Al-Omari, Ahmad Karkash, Razan Mansour, Nisreen Amayiri, Maisa Swaidan, Maysa Al-Hussaini. Medulloepithelioma with Heterologous Osteoid Component. A Case Report and Review of Literature. Child’s Nervous Sys.2019 Jan 8. doi: 10.1007/s00381-018-04041-8.
Al-Hussaini M.Histology of Primary Brain Tumors. In "Brain Tumors / Book 1", ISBN 980-953-307-721-0. Published by InTech, April 2013.
Al-Hussaini M, Al-Omari A. Case Study: Research Ethics Committee at King Hussein Cancer Center, Jordan.Published in Ethical Issues in Research in the Arab Region. Editor; H. Silverman. Published by Springer.
Al-Hussaini M. Case Study: Research Ethics Committee at King Hussein Cancer Center, Jordan. Published in Ethical Issues in Research in the Arab Region. Editor; H. Silverman. Published by Springer.
Eagle E.C. Jr, Chevez-Barrios P,Al-Hussaini M, Wilson M.Retinoblastoma. Tumors of neurosensory retina. WHO Classification of Tumours of the Eye, 4th Edition. IARC, Lyon 2018. 111-117.
Margo C,Al-Hussaini M, Moulin A, Tso M.O.M.Retinocytoma.Tumors of neurosensory retina. WHO Classification of Tumours of the Eye, 4th Edition. IARC, Lyon 2018. 117-118.

Academic Rank

Full Member

Contact Information

Email Address: mhussaini@khcc.jo
Phone Number: 0096265300460-1308